Comparison between repaglinide plus metformin vs glimepiride plus metformin on glucose metabolism and lipoprotein (a) in type 2 diabetic patients: A 1-year study

被引：0
|
作者：
Ciccarelli, L
Derosa, G
Mugellini, A
Boschi, D
Ghelfi, M
Fogari, R
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A458 / A458
页数：1
相关论文
共 50 条
  • [31] Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: An application of the CORE Diabetes Model in type 2 diabetes
    Palmer, AJ
    Roze, S
    Lammert, M
    Valentine, WJ
    Minshall, ME
    Nicklasson, L
    Gall, MA
    Spinas, GA
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 : S41 - S51
  • [32] Metabolic variations with oral antidiabetic drugs in patients with type 2 diabetes: Comparison between glimepiride and metformin
    Derosa, G
    Franzetti, I
    Gadaleta, G
    Ciccarelli, L
    Fogari, R
    DIABETES NUTRITION & METABOLISM, 2004, 17 (03) : 143 - 150
  • [33] Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study
    Caturano, Alfredo
    Galiero, Raffaele
    Loffredo, Giuseppe
    Vetrano, Erica
    Medicamento, Giulia
    Acierno, Carlo
    Rinaldi, Luca
    Marrone, Aldo
    Salvatore, Teresa
    Monda, Marcellino
    Sardu, Celestino
    Marfella, Raffaele
    Sasso, Ferdinando Carlo
    BIOMEDICINES, 2023, 11 (02)
  • [34] Comparison of metabolic effects of pioglitazone, metformin, and glimepiride over 1 year in Japanese patients with newly diagnosed Type 2 diabetes
    Yamanouchi, T
    Sakai, T
    Igarashi, K
    Ichiyanagi, K
    Watanabe, H
    Kawasaki, T
    DIABETIC MEDICINE, 2005, 22 (08) : 980 - 985
  • [35] One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes
    Hanefeld, M
    Brunetti, P
    Schernthaner, GH
    Matthews, DR
    Charbonnel, BH
    DIABETES CARE, 2004, 27 (01) : 141 - 147
  • [36] Harmony 3 year 3 Results: albiglutide vs sitagliptin and glimepiride in patients with type 2 diabetes mellitus on metformin
    Matthews, J. E.
    Ahren, B.
    Ye, J.
    Carr, M. C.
    Stewart, M. W.
    DIABETOLOGIA, 2014, 57 : S337 - S337
  • [37] Improvement of glycaemic and lipid profiles with muraglitazar plus metformin in patients with type 2 diabetes: an active-control trial with glimepiride
    Rubin, Cindy J.
    Ledeine, Jean-Marie
    Fiedorek, Fred T.
    DIABETES & VASCULAR DISEASE RESEARCH, 2008, 5 (03): : 168 - 176
  • [38] Comparison between aspart and regular insulin in combination with metformin in Type 2 diabetic patients
    Rotella, CM
    Pala, L
    Dicembrini, I
    Mannucci, E
    DIABETOLOGIA, 2004, 47 : A266 - A267
  • [39] Fixed-Dose Combination of Dapagliflozin plus Sitagliptin plus Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations
    Sahay, Rakesh K.
    Giri, Richa
    Shembalkar, Jayashree V.
    Gupta, Sandeep K.
    Mohan, Brij
    Kurmi, Prakash
    Kumar, S. Ravindra
    Sawardekar, Vinayak M.
    Mishra, Ashutosh
    Murthy, L. Sreenivasa
    Arya, Vivek V.
    Sonawane, Abhijit R.
    Soni, Pravin N.
    Gofne, Sandip K.
    Karnawat, Shital R.
    Rajurkar, Mandodari N.
    Patel, Piyush M.
    Lakhwani, Lalit K.
    Mehta, Suyog C.
    Joglekar, Sadhna J.
    ADVANCES IN THERAPY, 2023, 40 (07) : 3227 - 3246
  • [40] Triple verses glimepiride plus metformin therapy on cardiovascular risk biomarkers and diabetic cardiornyopathy in insulin resistance type 2 diabetes mellitus rats
    Sharma, Ashish Kumar
    Srinivasan, B. P.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 38 (05) : 433 - 444
12345